相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anaphylaxis and Mast Cell Disease: What Is the Risk?
Cem Akin
CURRENT ALLERGY AND ASTHMA REPORTS (2010)
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
Alexandra Boehm et al.
EXPERIMENTAL HEMATOLOGY (2010)
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms
Ivan Alvarez-Twose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
Christine Bodemer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
Michel Arock et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
M. Niedoszytko et al.
ALLERGY (2009)
Assessing anaphylactic risk? Consider mast cell clonality
Dean D. Metcalfe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
K. Brockow et al.
ALLERGY (2008)
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis
K. J. Aichberger et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
David Gonzalez De Olano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes
S Florian et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine
A Pardanani et al.
LEUKEMIA RESEARCH (2004)
Diagnosis and classification of mast cell proliferative disorders: Delineation from immunologic diseases and non-mast cell hernatopoietic neoplasms
P Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Systemic mastocytosis
C Akin et al.
ANNUAL REVIEW OF MEDICINE (2004)
Cladribine therapy for systemic mastocytosis
HC Kluin-Nelemans et al.
BLOOD (2003)
Diagnosis and treatment of systemic mastocytosis: State of the art
P Valent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Mastocytosis: current concepts in diagnosis and treatment
L Escribano et al.
ANNALS OF HEMATOLOGY (2002)
Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis -: Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma
L Escribano et al.
LEUKEMIA RESEARCH (2002)
Serum tryptase levels in patients with mastocytosis: Correlation with mast cell burden and implication for defining the category of disease
WR Sperr et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Kit and c-kit mutations in mastocytosis:: A short overview with special reference to novel molecular and diagnostic concepts
F Féger et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
HP Horny et al.
LEUKEMIA RESEARCH (2001)
Variable expression of activation-linked surface antigens on human mast cells in health and disease
F Valent et al.
IMMUNOLOGICAL REVIEWS (2001)
Treatment of systemic mast-cell disease with cladribine
A Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
